Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Lifecare AS (LIFEA)

Oslo
Currency in NOK
Disclaimer
2.70
-0.15(-5.26%)
Closed

LIFEA Comments

down to 2,6
Buy now 5x in 2 yrs
Bottom is in imo.
https://m.marketscreener.com/quote/stock/LIFECARE-AS-111327906/news/Lifecare-Digid-ndash-a-medical-device-startup-worth-a-look-in-2021-31959666/
Suspecting nkr 6-8 during December. Triggers: Approval from german authorities and FDA
Norwegians are crayzy bout this stock. Expected FDA approval in days now.
Target acheived 8,35 atm
Let’s go!
Watch this stock on monday!
https://cordis.europa.eu/project/id/951933
Lifecare is the only commercial player that received funds from eu.
https://daily2dailynews.com/roundup-digital-immunity-passports-to-ramp-up-testing-london-tech-week-on-ai-in-healthcare-and-more-briefs/
Lifecare owns 25% of German company Digital Diagnostics mentioned in the article.
will be up at least 40% in +/- 1 month. Price atm nkr 5,65. Target at least nkr 8
This will go sky high again when 5 min Covid test is approved by US and German authorities in sept/ oct.
FDA approvsl just weeks ahead
https://www.prnewswire.com/news-releases/first-rapid-corona-antigen-test-approved-for-clinical-study-in-germany-301118181.html
https://www.prnewswire.com/news-releases/first-rapid-corona-antigen-test-approved-for-clinical-study-in-germany-301118181.html
Very interesting products. Unique Covid 5 min test will be ready from mid may. Company is also developing a glucose test. Could go 200-300% this year imo.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.